TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,754,000 | +185.2% | 209,355 | +1.8% | 0.08% | +161.3% |
| Q1 2022 | $5,524,000 | -21.2% | 205,747 | +40.0% | 0.03% | -18.4% |
| Q4 2021 | $7,010,000 | +61.6% | 146,952 | +125.1% | 0.04% | +35.7% |
| Q3 2021 | $4,337,000 | -45.5% | 65,284 | -36.0% | 0.03% | -49.1% |
| Q2 2021 | $7,959,000 | +204.7% | 102,009 | +269.4% | 0.06% | +189.5% |
| Q1 2021 | $2,612,000 | +211.7% | 27,615 | +301.5% | 0.02% | +171.4% |
| Q4 2020 | $838,000 | -83.8% | 6,878 | -88.4% | 0.01% | -83.7% |
| Q3 2020 | $5,186,000 | +438.0% | 59,359 | +283.5% | 0.04% | +126.3% |
| Q4 2019 | $964,000 | – | 15,478 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |